Brief: Karolinska Development's Portfolio Company OssDsign Gets FDA Clearance For New Major Indication

Kdventures AB

19/09/2023 07:06

Sept 19 (Reuters) - Karolinska Development AB  KDEV.ST :
    * KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY OSSDSIGN HAS
RECEIVED
FDA CLEARANCE FOR A NEW MAJOR INDICATION
    * ITS PORTFOLIO COMPANY OSSDSIGN HAS RECEIVED CLEARANCE FROM
FDA
FOR USE OF OSSDSIGN CATALYST IN INTERBODY CAGES IN SPINAL
SURGERY
    * KAROLINSKA DEVELOPMENT'S SHAREHOLDING IN OSSDSIGN,
INCLUDING
INDIRECT OWNERSHIP VIA KCIF CO-INVESTMENT FUND, AMOUNTS TO 10.4
PERCENT

Source text for Eikon:  ID:nGNEcbhbvq 
Further company coverage:  KDEV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))